Cite
Neuroblastoma With Opsoclonus-Myoclonus-Ataxia Syndrome: Role of Chemotherapy in the Management: Experience From a Tertiary Care Center in a Resource-limited Setting.
MLA
Anand, Sachit, et al. “Neuroblastoma With Opsoclonus-Myoclonus-Ataxia Syndrome: Role of Chemotherapy in the Management: Experience From a Tertiary Care Center in a Resource-Limited Setting.” Journal of Pediatric Hematology/Oncology, vol. 43, no. 7, Oct. 2021, pp. e924–29. EBSCOhost, https://doi.org/10.1097/mph.0000000000002131.
APA
Anand, S., Agarwala, S., Jain, V., Bakhshi, S., Dhua, A., Gulati, S., Seth, R., Srinivas, M., Jana, M., Kandasamy, D., & Bhatnagar, V. (2021). Neuroblastoma With Opsoclonus-Myoclonus-Ataxia Syndrome: Role of Chemotherapy in the Management: Experience From a Tertiary Care Center in a Resource-limited Setting. Journal of Pediatric Hematology/Oncology, 43(7), e924–e929. https://doi.org/10.1097/mph.0000000000002131
Chicago
Anand, Sachit, Sandeep Agarwala, Vishesh Jain, Sameer Bakhshi, Anjan Dhua, Sheffali Gulati, Rachna Seth, et al. 2021. “Neuroblastoma With Opsoclonus-Myoclonus-Ataxia Syndrome: Role of Chemotherapy in the Management: Experience From a Tertiary Care Center in a Resource-Limited Setting.” Journal of Pediatric Hematology/Oncology 43 (7): e924–29. doi:10.1097/mph.0000000000002131.